Sports Industry Maverick and Marketing Pioneer Joins Vestiage Advisory Committee
Newport Beach, California (PRWEB) November 13, 2013
Vestiage, a leading edge science based anti-aging company specializing in nutraceuticals and cosmeceuticals, announced today that Evan Morgenstein agreed to join the Vestiage Advisory Committee.
Morgenstein is the President and CEO of CelebExperts and PMG Sports where he has consulted with Fortune 10 companies as well as crafted celebrity spokespeople deals for some of the most famous personalities in pop culture including TV stars, athletes, celebrity chefs, home & garden experts, movie stars and musicians.
Evan Morgenstein said, "I am very impressed with what Scott Kimball and Vestiage have lined up in the supplement and anti-aging category. It is in line with where my firm sees huge growth in retail and on-line sales over the next 5 years. After negotiating with Scott to have Olympic icon Dara Torres as the company’s spokesperson, I started seeing the vision and growth model for the company. I find it inspiring and way out in front of their competitors. I am looking forward to providing my skills and experience as we build a company that defines the industry in helping people."
Scott Kimball, CEO of Vestiage stated, "Evan has been a serious supporter of Vestiage for some time now and is incredible at locating the right high quality athletes and celebrities for corporations like Vestiage. As our brand family grows, so will our need for his advice and guidance. We are grateful that he accepted our invitation to join the Advisory Committee and I look forward to working with him for a long time."
Morgenstein is the Founder of PMG Sports Management where he has represented over 400 Olympic Gold Medalists during his career and has recently appeared as a key player in the return of professional beach volleyball. He represents 6 of the top 8 AVP Tour players. In addition to brokering corporate sponsors and major sports franchises, he is a specialist in finding the appropriate sports talent for companies that need endorsement personalities.
Morgenstein will be focused on the Company's future release of products tied to sports personalities, key endorsement agreements and specialized sports marketing projects for the Company's brands.
Vestiage (stock symbol "VEST") is a publicly traded anti-aging company offering premium branded, science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the mission of extending the quality of an active life using human stem cell, marine/ocean, and cutting edge botanically based science and patented botanical ingredients to produce pure, highly potent and effective products. Vestiage creates and distributes cosmeceuticals such as Reluma (http://www.RelumaSkinCare.com) and multifunctional nutraceuticals through Monterey Bay Nutraceuticals (http://www.MontereyBayNutra.com) and RegiMEN™. Vestiage's branded products address the top “in demand” anti-aging consumer concerns. Vestiage research is focused on extending the quality of an active life and human performance science that covers both the cognitive and physical realms. To learn more, please visit the Company website, http://www.VestiageInc.com.
This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forwardlooking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiency and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control.